Lynx1 Capital Management LP: DENALI THERAPEUTICS INC (DNLI): Quarterly 13F Position History
As of Q1 2026, Lynx1 Capital Management LP reported 1,880,303 shares of DENALI THERAPEUTICS INC (DNLI), worth $36.1M and representing 5.7% of its 13F equity book. Quarter-over-quarter share count change: + 141,553 (+8.1%) . The position first appeared in Q3 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.
- 1,880,303Shares Held (Latest Filing)
- $36.1MReported Market Value (Latest Filing)
- 5.7%Portfolio Weight (% of 13F Equity Book)
- +141,553Quarter-over-Quarter Share Change
- +$7.4MQuarter-over-Quarter Value Change
- 1,880,303Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,880,303 | +141,553 | +8.1% | $36.1M | 5.7% | $19.2 |
| Q4 2025 | 1,738,750 | +1,477,063 | +564.4% | $28.7M | 5.8% | $16.5 |
| Q3 2025 | 261,687 | — | — | $3.8M | 0.8% | $14.5 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Lynx1 Capital Management LP first disclose a DNLI position in 13F-HR filings?
Lynx1 Capital Management LP first reported DENALI THERAPEUTICS INC (DNLI) on its 13F-HR filing for the period ending 2025-09-30 (Q3 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.
What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in DNLI?
Between Q4 2025 and Q1 2026, Lynx1 Capital Management LP added 141,553 shares of DNLI (+8.1%), bringing the total reported position to 1,880,303 shares at a market value of $36.1M.
Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in DNLI?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.